(4-Chloro-1-methyl-1H-pyrazol-5-yl)methylamine hydrochloride, 95.0%, 250mg

N2-Isobutyryl-2'-O-methylguanosine, 250mg

Tetramethylammonium Hydroxide Pentahydrate>97.0%(T)100g

(4R,4'R)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 100mg

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.50 µm, 1 Piece(s)

ESONARIMOD, 95%, 5mg

5-formyl-2-methoxyphenyl acetate, 95.0%, 25g

1-((3aS,6R,7aR)-8,8-Dimethyl-2,2-dioxidohexahydro-1H-3a,6-methanobenzo[c]isothiazol-1-yl)propan-1-one, 95.0%, 5g

2-(2-Bromoethyl)-2-methyl-1,3-dioxolane, 98%, 5g

3-Methyl-quinoxaline-2-carboxylic acid benzyl ester, 95.0%, 1g

2,5,8,11,14-Pentaoxahexadecan-16-amine, 98%, 250mg

1-(6-Methylpyridin-3-yl)hydrazine hydrochloride, 95.0%, 10g

2-Cyclobutyl-1,3-thiazole-5-carbaldehyde, 98%, 1g